FindMyKOL
Clinical trialNCT07442981CompletedObservational

Preoperative Dietary Fat Consumption and Baseline Inflammatory Markers

NCT07442981 is an observational study sponsored by Ohio State University. As of 18 Nov 2026, it is completed. It studies Fat Consumption and Inflammatory Markers. The registry lists an enrollment of 62 participants at 1 site in 1 country. The registry lists a start date of 25 Mar 2025 and a primary completion date of 30 Jan 2026.

SponsorOhio State University →Enrollment62Fat ConsumptionInflammatory Markers
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT07442981
FieldValue
Registry IDNCT07442981
StatusCompleted
Study typeObservational study
Lead sponsorOhio State University
Enrollment62
Registered sites1
Countries1
ConditionsFat Consumption and Inflammatory Markers
Start25 Mar 2025
Primary completion30 Jan 2026
Study completion30 Jan 2026
Last update posted2 Mar 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This single-center, prospective pilot study will examine dietary fat consumption and its relationship with inflammatory markers before surgery and the incidence of perioperative neurocognitive disorders in older surgical patients. The study will assess the feasibility getting diet-related information in a surgical setting and will establish baseline dietary patterns in older adults. It will also measure the incidence of postoperative cognitive impairment (POCI) in patients with high fat consumption and gather patient perspectives to inform future nutrition-focused interventions for older surgical candidates.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • the Ohio State University Wwexner Medical Center

    Columbus

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT07442981

Each answer restates registry values shown on this page.

What is NCT07442981?

NCT07442981 is an observational study sponsored by Ohio State University. It studies Fat Consumption and Inflammatory Markers.

Who leads NCT07442981?

The registry names Michelle Humeidan (principal investigator, Ohio State University) as the overall official.

Where does NCT07442981 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT07442981 end?

The registry lists a primary completion date of 30 Jan 2026 and a study completion date of 30 Jan 2026. The sponsor last updated the record on 2 Mar 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.